Global Transport Media Market Size (2024 - 2029)

Transport Media Market Analysis

The transport media market is expected to register a CAGR of 4.8% over the forecast period, 2022-2027.

With the rising COVID-19 testing, the demand for transport media is increased. For tests to be accurate and reliable, the quality of the specimen and the transporting and storing conditions of the specimen before being processed are crucial. For this, the use of a viral transport medium became common, and its demand increased exponentially. Key companies dealing the market started mass production of a viral transport medium for the transportation of nasopharyngeal and oropharyngeal swab specimens to diagnostic laboratories for confirmation.

For instance, in August 2020, Thermo Fisher Scientific opened its new USD 40 million facility in Lenexa, dedicated to viral transport media (VTM) production and enabled production to scale from 50,000 viral transport media tubes to more than 8 million per week. Additionally, According to the article titled "FDA Approved COVID-19 Innovations; Ohio State Medical Center To Share Nationwide" published in the Ohio State University Wexner Medical Center, in April 2020, the Food and Drug Administration (FDA) has approved VTM solutions developed by experts at The Ohio State University Wexner Medical Center to expand and speed up COVID-19 testing across Ohio. By the above mentioned factors there is a significant positive impact on the transport media market during the forecast period.

Further, increasing prevalence of infectious diseases, and growing number of initiatives adopted by government for increasing the adoption rate of testing kits are among the major factors driving the growth of the studied market. Infectious diseases are a major cause of human suffering in terms of both morbidity and mortality throughout human history. For instance, according to the United Nations Programs on HIV/AIDs (UNAIDS), in 2019 approximately 38 million people diagnosed with HIV/AIDS. Such factors are likely to boost the adoption of transport media market, thereby contributing to the studied market growth.

In recent years, a wide range of in vitro diagnostic tests has become available for use in resource-constrained settings. According to the article titled "NIH awards funding to develop 12 new rapid diagnostic tests for SARS-CoV-2" in October 2021, the National Institutes of Health (NIH) announced a USD 78 million grant to develop and produce 12 new rapid diagnostic tests for SARS-CoV-2, as the with the goal of bringing new home and point-of-care tests that can detect various respiratory illnesses to market in the year 2021. As the rapid test can be performed using VTM samples, allowing for the rapid identification and isolation of SARS-CoV-2 infected patients. This is liekly to boost the market growth.

The Global Fund to Fight AIDS, Tuberculosis, and Malaria has compiled a list of in vitro diagnostic tests that are eligible for procurement, based on WHO recommendations and on products approved by the regulatory authorities of the Global Harmonization Task Force. For instance, according to the WHO in October 2021, the use of lateral flow immunoassays to directly identify SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions offers a faster and less expensive means of testing for SARS-CoV-2 than nucleic acid amplification tests (NAATs). Therefore, the rising radoption of transport media is poised to accelerate market growth globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, In July 2020, EKF Diagnostics, announced launching of new product namely, PrimeStore MTM (Molecular Transport Medium). It is a new addition of novel transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product portfolio. Thus, owing to the product launches and acquisitions, the studied market is expected to have significant growth over the forecast period.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, Clinical and technical issues related to swabs collection and transport media is likely to impede market growth.

Transport Media Industry Segmentation

As per the scope of the report, Transport media are buffer solutions containing carbohydrates, peptones, and other nutrients, apart from growth factors, designed for the transport of microorganisms while preserving the viability of the microbe. Transport media are designed to arrest any growth of the microbial sample. The transport media market is segmented by Product (Viral Transport Media, Universal Transport Media, Molecular Transport Media and Others), Application (Diagnosis and Preclinical Testing), and End-Users (Hospitals, Clinics, Microbiology laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.